[3H]L-NG-Nitroarginine Binding after Transient Focal Ischemia and NMDA-Induced Excitotoxicity in Type I and Type III Nitric Oxide Synthase Null Mice
Open Access
- 1 May 1997
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 17 (5), 515-526
- https://doi.org/10.1097/00004647-199705000-00005
Abstract
We investigated the density and distribution of nitric oxide synthase (NOS) binding by quantitative autoradiography using [3H]L- NG-nitroarginine ([3H]L-NNA) after transient focal ischemia or intrastriatal injection of N-methyl-D-aspartate (NMDA) in wild-type (SV-129 and C57black/6) and type I (neuronal) and type III (endothelial) NOS-deficient mice. The middle cerebral artery (MCA) was occluded by an intraluminal filament for 3 h followed by 10 min to 7 days of reperfusion. Specific [3H]L-NNA binding, observed in the wild-type and type III mutant mouse at baseline, increased by 50–250% in the MCA territory during ischemia and the first 3 h of reperfusion. The density of binding sites ( Bmax), but not the dissociation constant ( Kd), increased significantly during the ischemic period as did type I NOS mRNA as detected by quantitative reverse transcription polymerase chain reaction. [3H]L-NNA binding after intrastriatal NMDA injection also increased by 20–230%. In the type I NOS-deficient mouse, [3H]L-NNA binding was low and only a very small increase was observed after ischemia or excitotoxicity. Under conditions of this study, [3H]L-NNA did not bind to type II NOS as there was no difference in the distribution or density of [3H]L-NNA binding in the rat spleen obtained after lipopolysaccharide treatment despite induction of NOS type II catalytic activity. Our data suggest that an ischemic/excitotoxic insult up-regulates type I NOS gene expression and [3H]L-NNA binding and that this up-regulation may play a pivotal role in the pathogenesis of ischemic/excitotoxic diseases.Keywords
This publication has 32 references indexed in Scilit:
- Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ DomainsCell, 1996
- Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth‐retarded and pre‐eclamptic pregnanciesBritish Journal of Pharmacology, 1995
- Marked Induction of Calcium-Independent Nitric Oxide Synthase Activity after Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1995
- Elevation of Plasma Nitric Oxide End Products during Focal Cerebral Ischemia and Reperfusion in the RatJournal of Cerebral Blood Flow & Metabolism, 1994
- Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.Stroke, 1994
- Nitric oxide production during focal cerebral ischemia in rats.Stroke, 1993
- Characterization of the binding of [3H]-l-NG-nitro-arginine in rat brainBritish Journal of Pharmacology, 1993
- Nitric Oxide Measured by a Porphyrinic Micro Sensor in Rat Brain after Transient Middle Cerebral Artery OcclusionJournal of Cerebral Blood Flow & Metabolism, 1993
- Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphoraseNeuron, 1991
- Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.Proceedings of the National Academy of Sciences, 1990